Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederic G Barr

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
American Journal of Medical Genetics. Part A|April 20, 2022
Late-onset Proteus syndrome with cerebriform connective tissue nevus and subsequent development of intraductal papillomaEmily W Modlin, Anne M Slavotinek, Thomas N Darling, et al.
Molecular Cancer Therapeutics|November 20, 2025
Involvement of the FGF8/FGF receptor signaling pathway in the maintenance and progression of fusion-positive rhabdomyosarcomaSalah Boudjadi, Hana Kim, Bishwanath Chatterjee, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|January 5, 2005
Sclerosing rhabdomyosarcomas in children and adolescents: a clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology GroupMelissa C Chiles, David M Parham, Stephen J Qualman, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2023
Rhabdomyosarcomas are oncogene addicted to the activation of AVILZhongqiu Xie, Pawel L Janczyk, Xinrui Shi, et al.
Genes, Chromosomes & Cancer|January 25, 2002
Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypesJulia A Bridge, Jian Liu, Stephen J Qualman, et al.
The American Journal of Surgical Pathology|December 3, 2002
Detection and diagnostic utilization of placental alkaline phosphatase in muscular tissue and tumors with myogenic differentiationJeffrey D Goldsmith, Bruce Pawel, John R Goldblum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2011
Genomic and clinical analysis of amplification of the 13q31 chromosomal region in alveolar rhabdomyosarcoma: a report from the Children's Oncology GroupJennifer L Reichek, Fenghai Duan, Lynette M Smith, et al.
Pediatric Blood & Cancer|March 26, 2013
PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: a children's oncology group reportStephen X Skapek, James Anderson, Frederic G Barr, et al.
European Journal of Endocrinology|July 21, 2022
Novel GLCCI1-BRAF fusion drives kinase signaling in a case of pheochromocytomatosisBenjamin L Green, Robert R C Grant, Christopher T Richie, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 15, 2024
Novel PAX3::MAML3 Fusion Identified in Alveolar Rhabdomyosarcoma, Using DNA Methylation Profiling to Expand the Genetic Spectrum of "Fusion-Positive" CasesJosephine K Dermawan, Faizan Malik, John M Gross, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
American Journal of Medical Genetics. Part A|April 20, 2022
Late-onset Proteus syndrome with cerebriform connective tissue nevus and subsequent development of intraductal papillomaEmily W Modlin, Anne M Slavotinek, Thomas N Darling, et al.
Molecular Cancer Therapeutics|November 20, 2025
Involvement of the FGF8/FGF receptor signaling pathway in the maintenance and progression of fusion-positive rhabdomyosarcomaSalah Boudjadi, Hana Kim, Bishwanath Chatterjee, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|January 5, 2005
Sclerosing rhabdomyosarcomas in children and adolescents: a clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology GroupMelissa C Chiles, David M Parham, Stephen J Qualman, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2023
Rhabdomyosarcomas are oncogene addicted to the activation of AVILZhongqiu Xie, Pawel L Janczyk, Xinrui Shi, et al.
Genes, Chromosomes & Cancer|January 25, 2002
Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypesJulia A Bridge, Jian Liu, Stephen J Qualman, et al.
The American Journal of Surgical Pathology|December 3, 2002
Detection and diagnostic utilization of placental alkaline phosphatase in muscular tissue and tumors with myogenic differentiationJeffrey D Goldsmith, Bruce Pawel, John R Goldblum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2011
Genomic and clinical analysis of amplification of the 13q31 chromosomal region in alveolar rhabdomyosarcoma: a report from the Children's Oncology GroupJennifer L Reichek, Fenghai Duan, Lynette M Smith, et al.
Pediatric Blood & Cancer|March 26, 2013
PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: a children's oncology group reportStephen X Skapek, James Anderson, Frederic G Barr, et al.
European Journal of Endocrinology|July 21, 2022
Novel GLCCI1-BRAF fusion drives kinase signaling in a case of pheochromocytomatosisBenjamin L Green, Robert R C Grant, Christopher T Richie, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 15, 2024
Novel PAX3::MAML3 Fusion Identified in Alveolar Rhabdomyosarcoma, Using DNA Methylation Profiling to Expand the Genetic Spectrum of "Fusion-Positive" CasesJosephine K Dermawan, Faizan Malik, John M Gross, et al.
Pageof 10